Test Bank For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson | LATEST

Test TCBank TCfor TCPharmacotherapeutics TCfor TCAdvanced TCPractice TCNurse TCPrescribers TC5th TCEdition

, Pharmacotherapeutics TCfor TCAdvanced TCPractice TCNurse TCPrescribers TC5th TCEdition TCWoo TCRobinson TCTest
TCBank




Chapter TC1. TCThe TCRole TCof TCthe TCNurse

PractitionerTCMultiple TCChoice
TC



Identify TCthe TCchoice TCthat TCbest TCcompletes TCthe TCstatement TCor TCanswers TCthe TCquestion.


TC TC TC TC 1. TCNurse TCpractitioner TCprescriptive TCauthority TCis TCregulated TCby:
1. The TCNational TCCouncil TCof TCState TCBoards TCof TCNursing
2. The TCU.S. TCDrug TCEnforcement TCAdministration
3. The TCState TCBoard TCof TCNursing TCfor TCeach TCstate
4. The TCState TCBoard TCof TCPharmacy

TC TC TC TC 2. TCThe TCbenefits TCto TCthe TCpatient TCof TChaving TCan TCAdvanced TCPractice TCRegistered TCNurse
TC(APRN) TCprescriberT include:
C

1. Nurses TCknow TCmore TCabout TCPharmacology TCthan TCother TCprescribers TCbecause
TCthey TCtake TCitTboth TCin TCtheir TCbasic TCnursing TCprogram TCand TCin TCtheir TCAPRN
C

TCprogram.

2. Nurses TCcare TCfor TCthe TCpatient TCfrom TCa TCholistic TCapproach TCand TCinclude TCthe
TCpatient TCinTdecision TCmaking TCregarding TCtheir TCcare.
C

3. APRNs TCare TCless TClikely TCto TCprescribe TCnarcotics TCand TCother TCcontrolled TCsubstances.
4. APRNs TCare TCable TCto TCprescribe TCindependently TCin TCall TCstates, TCwhereas TCa
TCphysician’sT assistant TCneeds TCto TChave TCa TCphysician TCsupervising TCtheir
C

TCpractice.



TC TC TC TC 3. TCClinical TCjudgment TCin TCprescribing TCincludes:
1. Factoring TCin TCthe TCcost TCto TCthe TCpatient TCof TCthe TCmedication TCprescribed
2. Always TCprescribing TCthe TCnewest TCmedication TCavailable TCfor TCthe TCdisease TCprocess
3. Handing TCout TCdrug TCsamples TCto TCpoor TCpatients
4. Prescribing TCall TCgeneric TCmedications TCto TCcut TCcosts
TC TC TC TC 4. TCCriteria TCfor TCchoosing TCan TCeffective TCdrug TCfor TCa TCdisorder TCinclude:
1. Asking TCthe TCpatient TCwhat TCdrug TCthey TCthink TCwould TCwork TCbest TCfor TCthem
2. Consulting TCnationally TCrecognized TCguidelines TCfor TCdisease TCmanagement
3. Prescribing TCmedications TCthat TCare TCavailable TCas TCsamples TCbefore TCwriting TCa TCprescription
4. Following TCU.S. TCDrug TCEnforcement TCAdministration TCguidelines TCfor TCprescribing
TC TC TC TC 5. TCNurse TCpractitioner TCpractice TCmay TCthrive TCunder TChealth-care TCreform TCbecause TCof:
1. The TCdemonstrated TCability TCof TCnurse TCpractitioners TCto TCcontrol TCcosts TCand
TCimprove TCpatientToutcomes
C

2. The TCfact TCthat TCnurse TCpractitioners TCwill TCbe TCable TCto TCpractice TCindependently
3. The TCfact TCthat TCnurse TCpractitioners TCwill TChave TCfull TCreimbursement TCunder
TChealth-careTreform
C

4. The TCability TCto TCshift TCaccountability TCfor TCMedicaid TCto TCthe TCstate TClevel

,Chapter TC1. TCThe TCRole TCof TCthe TCNurse
TCPractitionerTCAnswer TCSection

MULTIPLE TCCHOICE

1. ANS: 3 PTS: T C 1
2. ANS: 2 PTS: T C 1
3. ANS: 1 PTS: T C 1
4. ANS: 2 PTS: T C 1
5. ANS: 1 PTS: T C 1

Chapter TC2. TCReview TCof TCBasic TCPrinciples TCof

PharmacologyTCMultiple TCChoice
TC



Identify TCthe TCchoice TCthat TCbest TCcompletes TCthe TCstatement TCor TCanswers TCthe TCquestion.


TC TC TC TC 1. TCA TCpatient’s TCnutritional TCintake TCand TClaboratory TCresults TCreflect TChypoalbuminemia. TCThis
TCis TCcritical TCtoT
prescribing TCbecause:
C

1. Distribution TCof TCdrugs TCto TCtarget TCtissue TCmay TCbe TCaffected.
2. The TCsolubility TCof TCthe TCdrug TCwill TCnot TCmatch TCthe TCsite TCof TCabsorption.
3. There TCwill TCbe TCless TCfree TCdrug TCavailable TCto TCgenerate TCan TCeffect.
4. Drugs TCbound TCto TCalbumin TCare TCreadily TCexcreted TCby TCthe TCkidneys.
TC TC TC TC 2. TCDrugs TCthat TChave TCa TCsignificant TCfirst-pass TCeffect:
1. Must TCbe TCgiven TCby TCthe TCenteral TC(oral) TCroute TConly
2. Bypass TCthe TChepatic TCcirculation
3. Are TCrapidly TCmetabolized TCby TCthe TCliver TCand TCmay TChave TClittle TCif TCany TCdesired TCaction
4. Are TCconverted TCby TCthe TCliver TCto TCmore TCactive TCand TCfat-soluble TCforms
TC TC TC TC 3. TCThe TCroute TCof TCexcretion TCof TCa TCvolatile TCdrug TCwill TClikely TCbe TCthe:
1. Kidneys
2. Lungs
3. Bile TCand TCfeces
4. Skin

TC TC TC TC 4. TCMedroxyprogesterone TC(Depo TCProvera) TCis TCprescribed TCintramuscularly TC(IM) TCto
TCcreate TCa TCstorageT
reservoir TCof TCthe TCdrug. TCStorage TCreservoirs:
C

1. Assure TCthat TCthe TCdrug TCwill TCreach TCits TCintended TCtarget TCtissue
2. Are TCthe TCreason TCfor TCgiving TCloading TCdoses
3. Increase TCthe TClength TCof TCtime TCa TCdrug TCis TCavailable TCand TCactive
4. Are TCmost TCcommon TCin TCcollagen TCtissues
TC TC TC TC 5. TCThe TCNP TCchooses TCto TCgive TCcephalexin TCevery TC8 TChours TCbased TCon TCknowledge TCof TCthe TCdrug’s:
1. Propensity TCto TCgo TCto TCthe TCtarget TCreceptor
2. Biological TChalf-life
3. Pharmacodynamics
4. Safety TCand TCside TCeffects

, TC TC TC TC 6. TCAzithromycin TCdosing TCrequires TCthat TCthe TCfirst TCday’s TCdosage TCbe TCtwice TCthose TCof TCthe
TCother TC4 TCdays TCof TCtheT
prescription. TCThis TCis TCconsidered TCa TCloading TCdose. TCA TCloading TCdose:
C

1. Rapidly TCachieves TCdrug TClevels TCin TCthe TCtherapeutic TCrange
2. Requires TCfour- TCto TCfive-half-lives TCto TCattain
3. Is TCinfluenced TCby TCrenal TCfunction
4. Is TCdirectly TCrelated TCto TCthe TCdrug TCcirculating TCto TCthe TCtarget TCtissues

TC TC TC TC 7. TCThe TCpoint TCin TCtime TCon TCthe TCdrug TCconcentration TCcurve TCthat TCindicates TCthe TCfirst TCsign TCof TCa
TCtherapeutic TCeffectT is TCthe:
C

1. Minimum TCadverse TCeffect TClevel
2. Peak TCof TCaction